Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/REVVITY-INC-12426/news/PerkinElmer-Horizon-Discovery-erweitert-sein-Genmodulations-Portfolio-um-die-branchenweit-erste-sy-32833214/?utm_source=whatsapp&utm_medium=social&utm_campaign=share